80 related articles for article (PubMed ID: 4376785)
21. Oestrogen and progesterone receptors in mammary tumours of male SHN mice grafted with pituitaries in comparison with females.
Nagasawa H; Yamamoto K; Furuichi R; Sakamoto S
Anticancer Res; 1994; 14(1A):61-5. PubMed ID: 8166457
[TBL] [Abstract][Full Text] [Related]
22. Oestrogen receptor activity and intranuclear translocation in ovarian-dependent and -independent rat mammary tumours [proceedings].
Hawkins RA; Scott KM; Freedman B
J Endocrinol; 1978 May; 77(2):63P-64P. PubMed ID: 660071
[No Abstract] [Full Text] [Related]
23. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents.
Matsuzawa A; Ikeda Y
Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137
[TBL] [Abstract][Full Text] [Related]
24. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines.
Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T
Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949
[TBL] [Abstract][Full Text] [Related]
25. Steroid hormone receptors in the rat mammary adenocarcinoma induced by N-hydroxy-N-2-fluorenylacetamide.
Li SA; Malejka-Giganti D; Li JJ
J Natl Cancer Inst; 1982 Jul; 69(1):41-5. PubMed ID: 6285063
[TBL] [Abstract][Full Text] [Related]
26. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
27. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
28. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
29. Influence of steroidal alkylating agents on the growth and estrogen binding capacity of R3230AC mammary carcinoma of the rat [proceedings].
Wittliff JL; Weidner N; Park DC; Everson RB; Hall TC
Cancer Treat Rep; 1978 Aug; 62(8):1260-2. PubMed ID: 688266
[No Abstract] [Full Text] [Related]
30. Proliferative responses of mouse mammary glands to 17 beta-estradiol and progesterone and modification by mouse mammary tumor virus.
Lee AE
J Natl Cancer Inst; 1983 Dec; 71(6):1265-9. PubMed ID: 6317935
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.
Zhang X; Mehta RG; Lantvit DD; Coschigano KT; Kopchick JJ; Green JE; Hedayat S; Christov KT; Ray VH; Unterman TG; Swanson SM
Carcinogenesis; 2007 Jan; 28(1):143-50. PubMed ID: 16916863
[TBL] [Abstract][Full Text] [Related]
32. Effects of estrogens and progesterone on GABA system in ovariectomized rat retina.
Macaione S; Ientile R; Lentini M; Di Giorgio RM
Ital J Biochem; 1981; 30(4):279-89. PubMed ID: 7298312
[TBL] [Abstract][Full Text] [Related]
33. [Studies on hormone dependency of breast cancer].
Uetsura T
Kumamoto Igakkai Zasshi; 1970 Aug; 44(8):722-31. PubMed ID: 5536338
[No Abstract] [Full Text] [Related]
34. Enhancement by retinyl acetate of hormone-induced mammary tumorigenesis in female GR/A mice.
Welsch CW; Goodrich-Smith M; Brown CK; Crowe N
J Natl Cancer Inst; 1981 Oct; 67(4):935-8. PubMed ID: 6944559
[TBL] [Abstract][Full Text] [Related]
35. Parallelism between oestrogen binding capacity and hormone responsiveness of mammary tumours in GR-A mice.
Terenius L
Eur J Cancer (1965); 1972 Feb; 8(1):55-8. PubMed ID: 5014575
[No Abstract] [Full Text] [Related]
36. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
Sonnenschein C; Ucci AA; Soto AM
J Natl Cancer Inst; 1980 May; 64(5):1147-52. PubMed ID: 6154169
[TBL] [Abstract][Full Text] [Related]
37. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
[TBL] [Abstract][Full Text] [Related]
38. Increased uptake of iodide by hormone-responsive compared to hormone-independent mammary tumors in GR mice.
Thorpe SM
Int J Cancer; 1976 Sep; 18(3):345-50. PubMed ID: 182648
[TBL] [Abstract][Full Text] [Related]
39. [Hormonal dependency of experimental mammary tumors induced by an estro-progestational combination].
Hannouche N; Samperez S; Rivière MR; Jouan P
C R Seances Soc Biol Fil; 1981; 175(6):744-8. PubMed ID: 6459817
[TBL] [Abstract][Full Text] [Related]
40. Cyclic biological expression in mouse mammary tumors.
Kiang DT; King M; Zhang HJ; Kennedy BJ; Wang N
Science; 1982 Apr; 216(4541):68-70. PubMed ID: 7063874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
